| Ident. | Authors (with country if any) | Title |
|---|
| 000C59 (2018) |
Luca Sancineto [Pologne] ; Nunzio Iraci [Italie] ; Oriana Tabarrini [Italie] ; Claudio Santi [Italie] | NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors. |
| 001077 (2016) |
Xueyi Lu [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Jiapei Yang [République populaire de Chine] ; Boshi Huang [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Fabao Zhao [République populaire de Chine] ; Zhongxia Zhou [République populaire de Chine] ; Erik De Clercq [Belgique] ; Dirk Daelemans [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach. |
| 001317 (2015) |
Boshi Huang [République populaire de Chine] ; Cuicui Li [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Tao Liu [République populaire de Chine] ; Mingyan Yu [République populaire de Chine] ; Lu Fu [République populaire de Chine] ; Yueyue Sun [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Jan Balzarini [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches. |
| 001365 (2015) |
Aidang Lu [République populaire de Chine] ; Yuanyuan Ma [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Zhenghong Zhou [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] | Application of "Hydrogen-Bonding Interaction" in Drug Design. Part 2: Design, Synthesis, and Structure-Activity Relationships of Thiophosphoramide Derivatives as Novel Antiviral and Antifungal Agents. |
| 001648 (2014) |
Liu Wang [République populaire de Chine] ; Ye Tian [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Hong Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Dongyue Li [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Xinyong Liu [République populaire de Chine] | Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach. |
| 001700 (2014) |
Xiao Li [République populaire de Chine] ; Xueyi Lu [République populaire de Chine] ; Wenmin Chen [République populaire de Chine] ; Huiqing Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Jan Balzarini [Belgique] ; Erik De Clercq [Belgique] ; Xinyong Liu [République populaire de Chine] | Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors. |
| 002197 (2011) |
Erik De Clercq [Belgique] | The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures |
| 002862 (2010) |
Karen Pugh-Clarke [Royaume-Uni] ; Sheila Donlon [Irlande (pays)] ; Margaret Mccann [Irlande (pays)] | CE: Continuing Education Article PREVENTION OF INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE PART 1: APPLICATION OF INFECTION CONTROL PRINCIPLES TO THE RENAL CARE ENVIRONMENT |
| 002991 (2009) |
Tommy R. Tong [États-Unis] | Therapies for coronaviruses. Part I of II -- viral entry inhibitors. |
| 002992 (2009) |
Tommy R. Tong [États-Unis] | Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle. |
| 002E67 (2009) |
Erik De Clercq [Belgique] | Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives |
| 002F82 (2008) |
Sara Cesarini [Italie] ; Andrea Spallarossa ; Angelo Ranise ; Olga Bruno ; Paolo La Colla ; Barbara Secci ; Gabriella Collu ; Roberta Loddo | Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate. |
| 002F83 (2008) |
Sara Cesarini [Italie] ; Andrea Spallarossa ; Angelo Ranise ; Paola Fossa ; Paolo La Colla ; Giuseppina Sanna ; Gabriella Collu ; Roberta Loddo | Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates. |
| 003460 (2008) |
Sara Cesarini [Italie] ; Andrea Spallarossa [Italie] ; Angelo Ranise [Italie] ; Paola Fossa [Italie] ; Paolo La Colla [Italie] ; Giuseppina Sanna [Italie] ; Gabriella Collu [Italie] ; Roberta Loddo [Italie] | Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates |
| 003869 (2007) |
Jindrich Cinatl Jr [Allemagne] ; Martin Michaelis [Allemagne] ; Hans W. Doerr [Allemagne] | The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology |
| 004294 (2006) |
C. Chalmers | Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one |
| 004762 (2005) |
Ralf D. Hess [Allemagne] ; Barbara C. G Rtner ; Patricia E. Garrett | Meeting report: Part II. Notes from the Twentieth Annual Clinical Virology Symposium. |
| 004776 (2005) |
Werner Köhler | Killed in action: Microbiologists and clinicians as victims of their occupation Part 4: Tick-borne Relapsing Fever, Malta Fever, Glanders, SARS |
| 004A35 (2005) |
K. N. Woodward [Royaume-Uni] | Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products |
| 004B68 (2005) |
Sandra L. Barcelona [États-Unis] ; Alexis A. Thompson [États-Unis] ; Charles J. Coté [États-Unis] | Intraoperative pediatric blood transfusion therapy: a review of common issues. Part I: hematologic and physiologic differences from adults; metabolic and infectious risks |
| 004D56 (2005) |
Naoyuki Masuda [Japon] ; Osamu Yamamoto [Japon] ; Masahiro Fujii [Japon] ; Tetsuro Ohgami [Japon] ; Jiro Fujiyasu [Japon] ; Toru Kontani [Japon] ; Ayako Moritomo [Japon] ; Masaya Orita [Japon] ; Hiroyuki Kurihara [Japon] ; Hironobu Koga [Japon] ; Shunji Kageyama [Japon] ; Mitsuaki Ohta [Japon] ; Hiroshi Inoue [Japon] ; Toshifumi Hatta [Japon] ; Masafumi Shintani [Japon] ; Hiroshi Suzuki [Japon] ; Kenji Sudo [Japon] ; Yasuaki Shimizu [Japon] ; Eiichi Kodama [Japon] ; Masao Matsuoka [Japon] ; Masatoshi Fujiwara [Japon] ; Tomoyuki Yokota [Japon] ; Shiro Shigeta [Japon] ; Masanori Baba [Japon] | Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives |
